Bcl-w Protects Hippocampus during Experimental Status Epilepticus
- 1 October 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 171 (4) , 1258-1268
- https://doi.org/10.2353/ajpath.2007.070269
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland (B466)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS39016, NS41935, NS47622)
- Wellcome Trust (GR076576)
- Health Research Board (871, RP/2005/24)
This publication has 46 references indexed in Scilit:
- Neuroprotection of Tat-GluR6-9c against Neuronal Death Induced by Kainate in Rat Hippocampus via Nuclear and Non-nuclear PathwaysJournal of Biological Chemistry, 2006
- Selectively increasing inducible heat shock protein 70 via TAT‐protein transduction protects neurons from nitrosative stress and excitotoxicityJournal of Neurochemistry, 2005
- Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: Contribution of delayed neuronal cell death to seizure-induced neuronal injuryNeurobiology of Disease, 2005
- Development of a model of seizure‐induced hippocampal injury with features of programmed cell death in the BALB/c mouseJournal of Neuroscience Research, 2004
- Cell Death: Critical Control PointsPublished by Elsevier ,2004
- Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemiaGene Therapy, 2003
- Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in miceAnnals of Neurology, 2002
- Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal deathCell Death & Differentiation, 2001
- Testicular degeneration in Bclw-deficient miceNature Genetics, 1998
- Enhanced LTP in Mice Deficient in the AMPA Receptor GluR2Neuron, 1996